2024-11-26 02:25:05
Samsung Biologics Shares Strategic Roadmap for Sustainable Growth at the 40th Annual JP Morgan Healthcare Conference
Corporate/ 2023-07-24
Samsung Biologics Shares Strategic Roadm...

INCHEON,South Korea,Jan. 13,2022-- Samsung Biologics (KRX: 207940.KS) announced its sustainable growth plan for this year at the 2022 Annual...

CStone announces phase 2 GEMSTONE-201 trial met primary endpoint of objective response rate (ORR) in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma (R/R ENKTL)
Corporate/ 2023-07-24
CStone announces phase 2 GEMSTONE-201 tr...

Sugemalimab has the potential to become the world\'s first immunotherapy to be approved for patients with relapsed or refractory extranodal ...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release